Trial · NCT05092360
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Nemvaleukin 6 mcg/kg and Pembrolizumab 200 mg | 184 | |
| Overall Study | STARTED | Pembrolizumab 200 mg | 27 | |
| Overall Study | STARTED | Nemvaleukin 6 mcg/kg | 55 | |
| Overall Study | STARTED | Investigator's Choice Chemotherapy | 190 | |
| Overall Study | Intent to Treat Population | Nemvaleukin 6 mcg/kg and Pembrolizumab 200 mg | 184 | |
| Overall Study | Intent to Treat Population | Pembrolizumab 200 mg | 27 | |
| Overall Study | Intent to Treat Population | Nemvaleukin 6 mcg/kg | 55 | |
| Overall Study | Intent to Treat Population | Investigator's Choice Chemotherapy | 190 | |
| Overall Study | Safety Set Population | Nemvaleukin 6 mcg/kg and Pembrolizumab 200 mg | 178 | |
| Overall Study | Safety Set Population | Pembrolizumab 200 mg | 26 | |
| Overall Study | Safety Set Population | Nemvaleukin 6 mcg/kg | 53 | |
| Overall Study | Safety Set Population | Investigator's Choice Chemotherapy | 175 | |
| Overall Study | COMPLETED | Nemvaleukin 6 mcg/kg and Pembrolizumab 200 mg | 0 | |
| Overall Study | COMPLETED | Pembrolizumab 200 mg | 0 | |
| Overall Study | COMPLETED | Nemvaleukin 6 mcg/kg | 0 | |
| Overall Study | COMPLETED | Investigator's Choice Chemotherapy | 0 | |
| Overall Study | NOT COMPLETED | Nemvaleukin 6 mcg/kg and Pembrolizumab 200 mg | 184 | |
| Overall Study | NOT COMPLETED | Pembrolizumab 200 mg | 27 | |
| Overall Study | NOT COMPLETED | Nemvaleukin 6 mcg/kg | 55 | |
| Overall Study | NOT COMPLETED | Investigator's Choice Chemotherapy | 190 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05092360/flow